Citrus Sinensis ID: 000254

Local Sequence Feature Prediction

Prediction and Method	Result

Residue Number Marker

Protein Sequence

Secondary Structure (Consensus)

Disordered Region (Consensus)

Transmembrane Helix (Consensus)

Signal Peptide (Consensus)

Coiled Coil (COILS)

--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------1400------1410------1420------1430------1440------1450------1460------1470------1480------1490------1500------1510------1520------1530------1540------1550------1560------1570------1580------1590------1600------1610------1620------1630------1640------1650------1660------1670------1680------1690------1700------1710------1720------1730------1740------1750------1760------1770------178

MASSEAVSRLSQVVAPALEKIIKNASWRKHSKLAHECKSVLERLNSAQKQLPSSPTESETEGSTPGPLHDGGPNEYSLSESEFILSPLINACGTGFLKIADPALDCIQKMIAYGYLRGEADPTGGPEAKFLSKLIESVCKCHDLGDDAVELLVLKTLLSAVTSMSLRIHGDCLLQIVRTCYDIYLGSKNVINQTTAKASLIQMLVIVFRRMEADSSTVPIQPIVVAELMDPMEKSDADRTMTMFVQGFITKIMQDIDGLLTPENKVSLSGHDGAFETTTVETTNPADLLDSTDKDMLDAKYWEISMYKTALEGRKGELVDGEGERDDDLEVQIGNKLRRDAFLVFRALCKLSMKTPPKEALADPQLMRGKIVALELLKILLENAGAVFRTSDRFLGAIKQYLCLSLLKNSASTLMIVFQLSCSIFMSLVSRFRAGLKAEIGVFFPMIVLRVLENVAQPNFQQKMIVLRFLEKLCIDSQILVDIFINYDCDVNSSNIFERMVNGLLKTAQGVPPSTATSLLPPQESTMKLEAMKCLVAILRSMGDWMNKQLRIPDPQSTKKFEAVENISSGPEPGTVPMANGNGDELVEGSDSHSEASSEISDVSTIEQRRAYKLELQEGISLFNRKPKKGIEFLINAKKVGNTPEEIAAFLKNASDLNKTLIGDYLGEREELPLKVMHAYVDSFDFQRMEFDEAIRIFLLGFRLPGEAQKIDRIMEKFAERYCKCNPKVFTSADTAYVLAYSVILLNTDSHNPMVKNKMSADDFIRNNRGIDDGKDLPEEYLRSLFERISRNEIKMKGDDLAVQQMQSMNSNRILGLDSILNIVIRKRGEEKYMETSDDLIRHMQEQFKEKARKSESVYHAATDVVILRFMIEACWAPMLAAFSVPLDQSDDEVIIALCLQGFRYAIRVTAVMSMKTHRDAFVTSLAKFTSLHSPADIKQKNIDAIKAIVTIADEDGNYLQEAWEHILTCVSRFEHLHLLGEGAPPDATFFAFPQSESEKSKQAKSTILPVLKKKGPGRIQYAAATVMRGAYDSAGIGGSASGVVTSEQMNNLVSNLNMLEQVGSSEMNRIFTRSQKLNSEAIIDFVKALCKVSMEELRSASDPRVFSLTKIVEIAHYNMNRIRLVWSSIWHVLSDFFVNIGCSENLSIAIFAMDSLRQLSMKFLEREELANYNFQNEFMKPFVIVMRKSNAVEIRELIIRCVSQMVLSRVNNVKSGWKSMFMVFTTAAYDDHKNIVLLAFEIIEKIIRDYFPYITETETTTFTDCVNCLIAFTNSRFNKDISLNAIAFLRFCATKLAEGDLSASSSNKDKEISAKIPPASPRPVKELKLENGEMIDKDDHLYFWFPLLAGLSELSFDPRPEIRKSALQVLFETLRNHGHLFSLPLWERVFDSVLFPIFDYVRHTIDPSGENSPGQGVDGDTGELDQDAWLYETCTLALQLVVDLFVKFYNTVNPLLRKVLMLLVSFIKRPHQSLAGIGIAAFVRLMSNAGNLFSDEKWLEVAESLKEAAKATLPDFSYLGSEDCMAEIAAKGQINVESSGSGLPDDDSENLRTQHLFACIADAKCRAAVQLLLIQAVMEIYNMYRPCLSAKNTLVLFEALHDIAYHAHKINSDHPLRSKLQEFGSMTQMQDPPLLRLENESFQICLTFLQNIILDRPPTYEEADVESHLVNLCQEVLQLYIETSNHGQTSESSASGQVRWLIPLGSGKRRELAARAPLIVATLQAICTLEETSFEKNLACFFPLLSSLISCEHGSNEIQVALSDMLDASVGPILLRTC

cccccccccccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccHHHHccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHccccHHHHHHHHcccccccHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHcccccccHHHHHHHHHHcccccHHHHHccccccccccHHHHHHHHHHcccccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHcccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEcccHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHcccccHHHHHHHHHHHHHHcHHHHHccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccccccccHcccccccccccccHHHHHccccccccccHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccc

*************VAPALEKIIKNASWRK**KLAH*CKSVL*****************************GGPNEYSLSESEFILSPLINACGTGFLKIADPALDCIQKMIAYGYLRGEADPTGGPEAKFLSKLIESVCKCHDLGDDAVELLVLKTLLSAVTSMSLRIHGDCLLQIVRTCYDIYLGSKNVINQTTAKASLIQMLVIVFRRMEADS*****************************************************************************************************************LEVQIGNKLRRDAFLVFRALCKLSMK******LADPQLMRGKIVALELLKILLENAGAVFRTSDRFLGAIKQYLCLSLLKNSASTLMIVFQLSCSIFMSLVSRFRAGLKAEIGVFFPMIVLRVLENVAQPNFQQKMIVLRFLEKLCIDSQILVDIFINYDCDVNSSNIFERMVNGLLKTAQ**********LPPQESTMKLEAMKCLVAILRSMGDWMNKQL************************************************************AYKLELQEGISLFNRKPKKGIEFLINAKKVGNTPEEIAAFLKNASDLNKTLIGDYLGEREELPLKVMHAYVDSFDFQRMEFDEAIRIFLLGFRLPGEAQKIDRIMEKFAERYCKCNPKVFTSADTAYVLAYSVILLNTDSHNPMVKNKMSADDFIRNNRGIDDGKDLPEEYLRSLFERISRNEIKMKGDD*************ILGLDSILNIVIRKRGEEKYMETSDDLIRHMQEQFKEKARKSESVYHAATDVVILRFMIEACWAPMLAAFSVPLDQSDDEVIIALCLQGFRYAIRVTAVMSMKTHRDAFVTSLAKFTSLHSPADIKQKNIDAIKAIVTIADEDGNYLQEAWEHILTCVSRFEHLHLLGEGAPPDA*********************************************************************NMLEQVGSSEMNRIFTRSQKLNSEAIIDFVKALCKVSMEELRSASDPRVFSLTKIVEIAHYNMNRIRLVWSSIWHVLSDFFVNIGCSENLSIAIFAMDSLRQLSMKFLEREELANYNFQNEFMKPFVIVMRKSNAVEIRELIIRCVSQMVLSRVNNVKSGWKSMFMVFTTAAYDDHKNIVLLAFEIIEKIIRDYFPYITETETTTFTDCVNCLIAFTNSRFNKDISLNAIAFLRFCATKLA*************************************IDKDDHLYFWFPLLAGLSELSFDPRPEIRKSALQVLFETLRNHGHLFSLPLWERVFDSVLFPIFDYVRHT*******************LDQDAWLYETCTLALQLVVDLFVKFYNTVNPLLRKVLMLLVSFIKRPHQSLAGIGIAAFVRLMSNAGNLFSDEKWLEVAESLKEAAKATLPDFSYLGS*******************************TQHLFACIADAKCRAAVQLLLIQAVMEIYNMYRPCLSAKNTLVLFEALHDIAYHAHKINSDHPLRSKLQEF*****MQ*PPLLRLENESFQICLTFLQNIILDRPPTYEEADVESHLVNLCQEVLQLYIETSN*************RWLIPLGSGKRRELAARAPLIVATLQAICTLEETSFEKNLACFFPLLSSLISCEHGSNEIQVALSDMLDASVGPILLRTC

xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Brefeldin A-inhibited guanine nucleotide-exchange protein 2	Activates the ARF proteins by exchanging bound GDP for free GTP. Plays a role in vesicular protein sorting.	confident	Q9LZX8
Brefeldin A-inhibited guanine nucleotide-exchange protein 3	Activates the ARF proteins by exchanging bound GDP for free GTP. Plays a role in vesicular protein sorting (By similarity). Involved both in the nuclear division phase and in the nuclear fusion phase.	probable	Q9LPC5
Brefeldin A-inhibited guanine nucleotide-exchange protein 1	Promotes guanine-nucleotide exchange on ARF1 and ARF3. Promotes the activation of ARF1/ARF3 through replacement of GDP with GTP. Involved in vesicular trafficking. Required for the maintenance of Golgi structure; the function may be independent of its GEF activity. Required for the maturaion of integrin beta-1 in the Golgi. Involved in the establishment and persistence of cell polarity during directed cell movement in wound healing. Proposed to act as A kinase-anchoring protein (AKAP) and may mediate crosstalk between Arf and PKA pathways. Inhibits GAP activity of MYO9B probably through competetive RhoA binding. The function in the nucleus remains to be determined.	probable	D4A631

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3LTL, chain A
Confidence level:very confident
Coverage over the Query: 609-797
View the alignment between query and template
View the model in PyMOL

Template: 1XSZ, chain A
Confidence level:very confident
Coverage over the Query: 604-813,837-956
View the alignment between query and template
View the model in PyMOL

Template: 2R09, chain A
Confidence level:very confident
Coverage over the Query: 602-850,870-951
View the alignment between query and template
View the model in PyMOL